HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cosmetics left out of Canadian organic regs

This article was originally published in The Rose Sheet

Executive Summary

Some sectors of the industry, including personal care and cosmetics, "have expressed concern that a number of organic products which are regulated at the provincial level are not included in the scope of application" of the proposed Organic Products Regulations published Feb. 14 in the Canada Gazette (Part I). The regs apply to food and drink intended for human consumption as well as food intended to feed livestock, including agricultural crops used for those purposes, and are to be enforced by the Canadian Food Inspection Agency (CFIA). According to a regulatory impact analysis statement, further consultation is needed to determine whether personal-care products and other outlying commodities "should fall under the proposed regulations or whether their organic status should be governed by another government department, agency or body." The organic regulations are slated to go into effect June 30 following a public comment period. The Organic Trade Association in Canada states: "When these regulations come into effect this summer, consumers will have a clear idea of what organic is, and will know the [CFIA] is monitoring and enforcing organic claims in the marketplace.

You may also be interested in...

Future Use Of Titanium Dioxide In Spray And Powder Cosmetics Hinges On SCCS Review

As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.

Nanobiotix CEO’s Expansion Plans Target ‘Millions’ Of Patients

Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.

Teva’s Austedo Fails In Tourette’s Syndrome

Two late-stage trials of Austedo have missed their endpoints in the neurological disorder, meaning Teva will miss out on an additional revenue stream from the VMAT2 inhibitor.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts